InvestorsHub Logo
Followers 17
Posts 581
Boards Moderated 0
Alias Born 05/18/2018

Re: raja48185 post# 306663

Monday, 04/12/2021 3:03:15 PM

Monday, April 12, 2021 3:03:15 PM

Post# of 462431
Price drop because...

PR said:

The respective ongoing placebo-controlled Phase 2 and Phase 2/3 ANAVEX®2-73 clinical studies in adult (AVATAR) and pediatric (EXCELLENCE) patients with Rett syndrome are expected to be completed by mid 2021 and 2H 2021, respectively.


Avatar was supposed to be done 2 months ago, but is pushed out to midyear by the PR, and it HAS 5 SITES AND ONLY 30 PATIENTS. BTW, originally, they guessed Avatar would be done almost a year ago. Powers of prognostication pretty poor.

The Excellence study is supposed to complete in next 2 months(per clinicaltrials.gov), yeah right. BUT IT HAS ONLY 2 SITES OPEN AND NEEDS 69 PATIENTS! The PR now says it will be done 2nd half of this year. Huh, how will even that delay work with two sites open, dont hold your breath.

Why are we sitting on all this cash and not opening sites for Excellence!

All supposed times are from clinicaltrials.gov.

And we give out huge options rewards????

Raja, just fleshing out your delay comment.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News